Evidence map›Paper›PMID 41562916›Full record

Trial reportMedical sciences (Basel, Switzerland)2026

Short- and Middle-Term Nephroprotective and Cardioprotective Effects of Pentoxifylline in Patients with Diabetic Nephropathy: A Randomized Controlled Trial.

Oliva Mejía-Rodríguez, Marcela Ávila-Díaz, Carmen Prado-Uribe, María Eugenia Galván-Plata, Helios Vega Gómez, Cleto Álvarez-Aguilar, Miguel Angel Cuevas-Budhart, Ramón Paniagua

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Medical sciences (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Oliva Mejía-RodríguezCentro de Investigación Biomédica de Michoacán, Instituto Mexicano del Seguro Social, Morelia C.P. 58341, Michoacán, Mexico.ORCID 0000-0001-7261-6419
Marcela Ávila-DíazCoordinación de Investigación en Salud, Instituto Mexicano del Seguro Social, Avenida Cuauhtémoc 330, Col. Doctores, Ciudad de Mexico C.P. 06725, Mexico.ORCID 0000-0001-8855-9682
Carmen Prado-UribeCoordinación de Investigación en Salud, Instituto Mexicano del Seguro Social, Avenida Cuauhtémoc 330, Col. Doctores, Ciudad de Mexico C.P. 06725, Mexico.
María Eugenia Galván-PlataCoordinación de Investigación en Salud, Instituto Mexicano del Seguro Social, Avenida Cuauhtémoc 330, Col. Doctores, Ciudad de Mexico C.P. 06725, Mexico.ORCID 0009-0009-8526-9925
Helios Vega GómezHospital General Regional 1, Instituto Mexicano del Seguro Social, Morelia C.P. 58341, Michoacán, Mexico.ORCID 0000-0003-0323-6871
Cleto Álvarez-AguilarCoordinación Auxiliar Médica de Investigación en Salud, Instituto Mexicano del Seguro Social, Morelia C.P. 58341, Michoacán, Mexico.ORCID 0000-0002-1608-1808
Miguel Angel Cuevas-BudhartCoordinación de Investigación en Salud, Instituto Mexicano del Seguro Social, Avenida Cuauhtémoc 330, Col. Doctores, Ciudad de Mexico C.P. 06725, Mexico.ORCID 0000-0002-3379-0147
Ramón PaniaguaCoordinación de Investigación en Salud, Instituto Mexicano del Seguro Social, Avenida Cuauhtémoc 330, Col. Doctores, Ciudad de Mexico C.P. 06725, Mexico.ORCID 0000-0003-3577-9707

Funding

Instituto Mexicano del Seguro Social (IMSS) R-2015-785-065
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cardiotonic AgentsDiabetic NephropathiesPentoxifyllineAgedAlbuminuriaFemaleGlomerular Filtration RateHumansMaleMiddle AgedCardiotonic AgentsPentoxifyllinecardioprotectionChronic Kidney DiseaseChronic Kidney Disease progressionnephroprotectionPentoxifyllineType 2 Diabetes mellitus

Identifiers

PMID41562916
PMCPMC12821668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.